Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 trial of GS-9620 plus tenofovir disoproxil fumarate in untreated chronic hepatitis B
2015-002017-30Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Chronic Hepatitis B (CHB) comparing GS-9620 + tenofovir disoproxil fumarate with Placebo + tenofovir disoproxil fumarate (2 arms). Primary endpoint: Change in serum HBsAg at Week 24. Started Nov 2015; status: completed.
02
Drugs
vesatolimod
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2015-002017-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002017-30.